Intact memory in TGF-Β1 transgenic mice featuring chronic cerebrovascular deficit: Recovery with pioglitazone

Journal of Cerebral Blood Flow and Metabolism

Volumn 31, Issue 1, 2011, Pages 200-211

  Nicolakakis, Nektaria ^a   Aboulkassim, Tahar ^a   Aliaga, Antonio ^a   Tong, Xin Kang ^a   Rosa Neto, Pedro ^a,b   Hamel, Edith ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

collagen; FDG PET; hypoperfusion; NAC; neurovascular coupling; PPAR

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; COLLAGEN; DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; TRANSFORMING GROWTH FACTOR BETA1;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD VESSEL REACTIVITY; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN PERFUSION; CEREBROVASCULAR DISEASE; CHOLINERGIC SYSTEM; COGNITION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MAZE TEST; MEMORY; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TRANSGENIC MOUSE; TREATMENT OUTCOME; WESTERN BLOTTING;

AGING; ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; COGNITION; FIBROSIS; FLUORODEOXYGLUCOSE F18; HYPOGLYCEMIC AGENTS; IMMUNOHISTOCHEMISTRY; LASER-DOPPLER FLOWMETRY; MAZE LEARNING; MEMORY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MIDDLE CEREBRAL ARTERY; MUSCLE, SMOOTH, VASCULAR; PARASYMPATHETIC NERVOUS SYSTEM; RADIOPHARMACEUTICALS; THIAZOLIDINEDIONES; TRANSFORMING GROWTH FACTOR BETA1; VIBRISSAE;

EID: 78650225540     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2010.78     Document Type: Article

References (41)

1. Agabiti-Rosei E, Heagerty AM, Rizzoni D (2009) Effects of antihypertensive treatment on small artery remodelling. J Hypertens 27:1107-14
2. Barros CA, Ekuni R, Moro MA, Pereira FM, Dos Santos Pereira MA, Milani H (2009) The cognitive and histopathological effects of chronic 4-vessel occlusion in rats depend on the set of vessels occluded and the age of the animals. Behav Brain Res 197:378-87
3. Bell RD, Zlokovic BV (2009) Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol 118:103-13
4. Caraci F, Battaglia G, Busceti C, Biagioni F, Mastroiacovo F, Bosco P, Drago F, Nicoletti F, Sortino MA, Copani A (2008) TGF-b1 protects against Ab-neurotoxicity via the phosphatidylinositol-3-kinase pathway. Neurobiol Dis 30:234-42
5. Cheng JS, Dubal DB, Kim DH, Legleiter J, Cheng IH, Yu GQ, Tesseur I, Wyss-Coray T, Bonaldo P, Mucke L (2009) Collagen VI protects neurons against Ab toxicity. Nat Neurosci 12:119-21
6. Christov A, Ottman J, Hamdheydari L, Grammas P (2008) Structural changes in Alzheimer's disease brain microvessels. Curr Alzheimer Res 5:392-5
7. Craft TK, Mahoney JH, Devries AC, Sarter M (2005) Microsphere embolism-induced cortical cholinergic deafferentation and impairments in attentional performance. Eur J Neurosci 21:3117-32
8. Dickson MR, Perry RT, Wiener H, Go RC (2005) Association studies of transforming growth factor-b1 and Alzheimer's disease. Am J Med Genet (Neuropsychiatr Genet) 139(Part B):38-41
9. Farkas E, Luiten PG (2001) Cerebral microvascular pathology in aging and Alzheimer's disease. Progress Neurobiol 64:575-611
10. Farkas E, Luiten PG, Bari F (2007) Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res Rev 54:162-80
11. Freitag MH, Peila R, Masaki K, Petrovitch H, Ross GW, White LR, Launer LJ (2006) Midlife pulse pressure and incidence of dementia: the Honolulu-Asia aging study. Stroke 37:33-7
12. Fu M, Zhang J, Zhu X, Myles DE, Willson TM, Liu X, Chen YE (2001) Peroxisome proliferator-activated receptor g inhibits transforming growth factor b-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3. J Biol Chem 276:45888-94
13. Gaertner RF, Wyss-Coray T, Von Euw D, Lesné S, Vivien D, Lacombe P (2005) Reduced brain tissue perfusion in TGF-beta 1 transgenic mice showing Alzheimer's disease-like cerebrovascular abnormalities. Neurobiol Dis 19:38-46
14. Galea E, Feinstein DL, Lacombe P (2006) Pioglitazone does not increase cerebral glucose utilisation in a murine model of Alzheimer's disease and decreases it in wildtype mice. Diabetologia 49:2153-61
15. Grammas P, Ovase R (2002) Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer's disease brain. Am J Pathol 160:1583-7
16. Han BH, Zhou ML, Abousaleh F, Brendza RP, Dietrich HH, Koenigsknecht-Talboo J, Cirrito JR, Milner E, Holtzman DM, Zipfel GJ (2008) Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma secretase inhibition. J Neurosci 28:13542-50.
17. Haydon PG, Carmignoto G (2006) Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev 86:1009-31
18. Hirao K, Ohnishi T, Hirata Y, Yamashita F, Mori T, Moriguchi Y, Matsuda H, Nemoto K, Imabayashi E, Yamada M, Iwamoto T, Arima K, Asada T (2005) The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT. Neuroimage 28:1014-21
19. Huang PH, Sata M, Nishimatsu H, Sumi M, Hirata Y, Nagai R (2008) Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice. Biomed Pharmacother 62:46-52
20. Iadecola C, Zhang F, Niwa K, Eckman C, Turner SK, Fischer E, Younkin S, Borchelt DR, Hsiao KK, Carlson GA (1999) SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci 2:157-61
21. Krupinski J, Kumar P, Kumar S, Kaluza J (1996) Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans. Stroke 27:852-7
22. Lacombe P, Mathews PM, Schmidt S, Breidert T, Heneka MT, Landreth GE, Feinstein DL, Galea E (2004) Effect of anti-inflammatory agents on transforming growth factor beta over-expressing mouse brains: a model revised. J Neuroinflammation 1:11-27
23. Lau JC, Lerch JP, Sled JG, Henkelman RM, Evans AC, Bedell BJ (2008) Longitudinal neuroanatomical changes determined by deformation-based morphometry in a mouse model of Alzheimer's disease. NeuroImage 42:19-27
24. Miki K, Ishibashi S, Sun L, Xu H, Ohashi W, Kuroiwa T, Mizusawa H (2009) Intensity of chronic cerebral hypoperfusion determines white/gray matter injury and cognitive/motor dysfunction in mice. J Neurosci Res 87:1270-81
25. Nicolakakis N, Aboulkassim T, Ongali B, Lecrux C, Fernandes P, Rosa-Neto P, Tong XK, Hamel E (2008) Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor g agonist. J Neurosci 28:9287-96
26. Park SW, Yi JH, Miranpuri G, Satriotomo I, Bowen K, Resnick DK, Vemuganti R (2007) Thiazolidinedione class of peroxisome proliferator-activated receptor g agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats. J Pharmacol Exp Ther 320:1002-12
27. Peterson MC (2005) Circulating transforming growth factor b-1: a partial molecular explanation for associations between hypertension, diabetes, obesity, smoking and human disease involving fibrosis. Med Sci Monit 11:RA229-32
28. Rosengarten B, Paulsen S, Molnar S, Kaschel R, Gallhofer B, Kaps M (2006) Acetylcholine esterase inhibitor donepezil improves dynamic cerebrovascular regulation in Alzheimer patients. J Neurol 253:58-64
29. Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, Breteler MM (2005) Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam study. Ann Neurol 57:789-94
30. Salins P, He Y, Olson K, Glazner G, Kashour T, Amara F (2008) TGF-b1 is increased in a transgenic mouse model of familial Alzheimer's disease and causes neuronal apoptosis. Neurosci Lett 430:81-6
31. Sun X, He G, Qing H, Zhou W, Dobie F, Cai F, Staufenbiel M, Huang LE, Song W (2006) Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci USA 103:18727-32
32. Tesseur I, Zou K, Esposito L, Bard F, Berber E, Van Can J, Lin AH, Crews L, Tremblay P, Mathews P, Mucke L, Masliah E, Wyss-Coray T (2006) Deficiency in neuronal TGF-b signaling promotes neurodegeneration and Alzheimer's pathology. J Clin Investigation 116:3060-9
33. Tong XK, Hamel E (1999) Regional cholinergic denervation of cortical microvessels and nitric oxide synthasecontaining neurons in Alzheimer's disease. Neuroscience 92:163-75
34. Tong XK, Hamel E (2007) Transforming growth factor-beta 1 impairs endothelin-1-mediated contraction of brain vessels by inducing mitogen-activated protein (MAP) kinase phosphatase-1 and inhibiting p38 MAP kinase. Mol Pharmacol 72:1476-83
35. Tong XK, Nicolakakis N, Kocharyan A, Hamel E (2005) Vascular remodeling versus amyloid b-induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimer's disease. J Neurosci 25:11165-74
36. Town T, Laouar Y, Pittenger C, Mori T, Szekely CA, Tan J, Duman RS, Flavell RA (2008) Blocking TGF-b-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nat Med 14:681-7
37. Ueberham U, Ueberham E, Brü ckner MK, Seeger G, Gärtner U, Gruschka H, Gebhardt R, Arendt T (2005) Inducible neuronal expression of transgenic TGF-b1 in vivo: dissection of short-term and long-term effects. Eur J Neurosci 22:50-64
38. Wyss-Coray T, Feng L, Masliah E, Ruppe MD, Lee HS, Toggas SM, Rockenstein EM, Mucke L (1995) Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-beta 1. Am J Pathol 147:53-67
39. Wyss-Coray T, Masliah E, Mallory M, McConlogue L, Johnson-Wood K, Lin C, Mucke L (1997) Amyloidogenic role of cytokine TGF-b1 in transgenic mice and in Alzheimer's disease. Nature 389:603-6
40. Yoshida T, Ha-Kawa S, Yoshimura M, Nobuhara K, Kinoshita T, Sawada S (2007) Effectiveness of treatment with donepezil hydrochloride and changes in regional cerebral blood flow in patients with Alzheimer's disease. Ann Nucl Med 21:257-65
41. Zhang F, Sowers JR, Ram JL, Standley PR, Peuler JD (1994) Effects of pioglitazone on calcium channels in vascular smooth muscle. Hypertension 24:170-5